Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center

Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center

Introduction: TTFields plus Temozolomide (TTFields/TMZ) extended survival versus TMZ alone in newly diagnosed glioblastoma (GBM) patients in the EF-14 trial. We have reported a retrospective analysis of newly diagnosed Chinese GBM patients who received TTFields/TMZ treatment and TMZ treatment from A...

Full description

Bibliographic Details
Main Authors: Chunjui Chen, Hao Xu, Kun Song, Yi Zhang, Junyan Zhang, Yang Wang, Xiaofang Sheng, Lingchao Chen, Zhiyong Qin
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Clinical Medicine
Subjects:
glioblastoma
tumor treating fields
chemotherapy
retrospective cohort
Online Access:https://www.mdpi.com/2077-0383/11/19/5855

Internet

https://www.mdpi.com/2077-0383/11/19/5855

Similar Items